Skip to main content

Table 2 Independent T-test of mean and 95% CI for mean level of liver enzymes of study participant at Debre Behan Referral Hospital, Northeast Ethiopia

From: Liver enzyme elevation in patients taking HAART compared with treatment naïve controls at Debre Berhan Referral Hospital: a comparative cross-sectional study, Northeast Ethiopia

Parameter

Study group

Number

Mean

95% CI for mean

p-value

ALT (U/L)

ART group

76

35.67

32.18–39.16

0.000*

Pre-ART group

76

23.97

21.38-26.57

AST (U/L)

ART group

76

36.05

32.88–39.23

0.000*

Pre-ART group

76

28.00

25.52–30.49

ALP (U/L)

ART group

76

117.14

97.99–136.30

0.022*

Pre-ART group

76

89.45

75.27–103.64

Total protein (g/dL)

ART group

76

7.09

6.89–7.30

0.007*

Pre-ART group

76

7.46

7.29–7.64

Total bilirubin (mg/dL)

ART group

76

0.787

0.761–0.813

0.000*

Pre-ART group

76

0.660

0.649–0.673

Direct bilirubin (mg/dL)

ART group

76

0.275

0.227–0.324

0.007*

Pre-ART group

76

0.188

0.149–0.228

Urea (mg/dL)

ART group

76

19.945

18.414–21.477

0.875

Pre-ART group

76

19.750

17.824–21.678

Creatinine (mg/dL)

ART group

76

0.588

0.562–0.614

0.016*

Pre-ART group

76

0.641

0.607–0.675

Hemoglobin (g/dL)

Treatment group

76

15.44

14.98–15.91

0.245

Pre-ART group

76

15.02

14.46–15.58

CD4 count (cells/µL)

ART group

76

428.14

367.75–488.53

0.362

Pre-ART group

76

390.97

336.93–445.01

  1. * Statistically significant